These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 19940426

  • 1. Treatment of aggressive ADHD in children and adolescents: conceptualization and treatment of comorbid behavior disorders.
    McBurnett K, Pfiffner LJ.
    Postgrad Med; 2009 Nov; 121(6):158-65. PubMed ID: 19940426
    [Abstract] [Full Text] [Related]

  • 2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM, Earls MF.
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [Abstract] [Full Text] [Related]

  • 3. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF, Miller A, Fine S.
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [Abstract] [Full Text] [Related]

  • 4. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P, Besana D, Mancini F, Rossi A, Poole L, Escobar R, Zuddas A, LYCY Study Group.
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [Abstract] [Full Text] [Related]

  • 5. [Family functioning and psychosocial characteristics in children with attention deficit hyperactivity disorder with comorbid oppositional defiant disorder or conduct disorder].
    Kiliç BG, Sener S.
    Turk Psikiyatri Derg; 2005 Nov; 16(1):21-8. PubMed ID: 15793695
    [Abstract] [Full Text] [Related]

  • 6. The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study.
    Biederman J, Petty CR, Dolan C, Hughes S, Mick E, Monuteaux MC, Faraone SV.
    Psychol Med; 2008 Jul; 38(7):1027-36. PubMed ID: 18205967
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
    Spencer TJ, Abikoff HB, Connor DF, Biederman J, Pliszka SR, Boellner S, Read SC, Pratt R.
    Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
    [Abstract] [Full Text] [Related]

  • 8. ADHD with comorbid oppositional defiant disorder or conduct disorder: discrete or nondistinct disruptive behavior disorders?
    Connor DF, Doerfler LA.
    J Atten Disord; 2008 Sep; 12(2):126-34. PubMed ID: 17934178
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder.
    Goez H, Back-Bennet O, Zelnik N.
    J Child Neurol; 2007 May; 22(5):538-42. PubMed ID: 17690058
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA, Pliszka SR.
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [Abstract] [Full Text] [Related]

  • 13. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
    Bangs ME, Hazell P, Danckaerts M, Hoare P, Coghill DR, Wehmeier PM, Williams DW, Moore RJ, Levine L, Atomoxetine ADHD/ODD Study Group.
    Pediatrics; 2008 Feb; 121(2):e314-20. PubMed ID: 18245404
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data.
    Biederman J, Spencer TJ, Newcorn JH, Gao H, Milton DR, Feldman PD, Witte MM.
    Psychopharmacology (Berl); 2007 Jan; 190(1):31-41. PubMed ID: 17093981
    [Abstract] [Full Text] [Related]

  • 18. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder.
    Kariyawasam SH, Zaw F, Handley SL.
    Neuro Endocrinol Lett; 2002 Feb; 23(1):45-8. PubMed ID: 11880861
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dysthymic disorder contributes to oppositional defiant behaviour in children with Attention Deficit Hyperactivity Disorder, combined type (ADHD-CT).
    Vance A, Sanders M, Arduca Y.
    J Affect Disord; 2005 Jun; 86(2-3):329-33. PubMed ID: 15935256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.